Cargando…

A SMART approach to reducing paroxysmal atrial fibrillation symptoms: Results from a pilot randomized controlled trial

BACKGROUND: Stress and negative emotions contribute to atrial fibrillation (AF). Mind-body practices decrease stress and negative emotions and may reduce AF episodes and improve quality of life for patients with AF. OBJECTIVE: We examined the effects of a multimodal mind-body program, the SMART Prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Dossett, Michelle L., Needles, Emma W., Donahue, Zachary, Gadenne, Gillian, Macklin, Eric A., Ruskin, Jeremy N., Denninger, John W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369288/
https://www.ncbi.nlm.nih.gov/pubmed/34430937
http://dx.doi.org/10.1016/j.hroo.2021.06.003
_version_ 1783739261484269568
author Dossett, Michelle L.
Needles, Emma W.
Donahue, Zachary
Gadenne, Gillian
Macklin, Eric A.
Ruskin, Jeremy N.
Denninger, John W.
author_facet Dossett, Michelle L.
Needles, Emma W.
Donahue, Zachary
Gadenne, Gillian
Macklin, Eric A.
Ruskin, Jeremy N.
Denninger, John W.
author_sort Dossett, Michelle L.
collection PubMed
description BACKGROUND: Stress and negative emotions contribute to atrial fibrillation (AF). Mind-body practices decrease stress and negative emotions and may reduce AF episodes and improve quality of life for patients with AF. OBJECTIVE: We examined the effects of a multimodal mind-body program, the SMART Program, on AF-related quality of life in patients with paroxysmal AF (PAF). METHODS: In this randomized, waitlist-controlled pilot trial, 18 subjects with PAF participated in an 8-week SMART Program delivered online immediately or 3 months later. Validated measures were completed at baseline and at 3 and 6 months (waitlist group only). RESULTS: Comparing pre- vs post-program scores among all 18 participants, subjects reported improvement in AF-related quality of life (Cohen’s d = 0.75, P = .005) and depression (d = 0.50, P = .05) but not anxiety (d = 0.35, P = .16). Subjects also reported improvements in AF symptom severity (P = .026), distress (P = .014), positive affect (P = .003), and ability to cope with stress (P = .001). Compared to waitlist control subjects, those in the immediate group reported improvement in positive affect (d = 1.20, P = .021) and coping with stress (d = 1.36, P = .011) after participating in the program. CONCLUSION: The SMART Program, delivered virtually, may enhance positive emotions and coping with stress as well as decrease negative emotions and AF symptoms. These results warrant a larger trial to better understand the potential benefits of such programs for patients with PAF.
format Online
Article
Text
id pubmed-8369288
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83692882021-08-23 A SMART approach to reducing paroxysmal atrial fibrillation symptoms: Results from a pilot randomized controlled trial Dossett, Michelle L. Needles, Emma W. Donahue, Zachary Gadenne, Gillian Macklin, Eric A. Ruskin, Jeremy N. Denninger, John W. Heart Rhythm O2 Clinical BACKGROUND: Stress and negative emotions contribute to atrial fibrillation (AF). Mind-body practices decrease stress and negative emotions and may reduce AF episodes and improve quality of life for patients with AF. OBJECTIVE: We examined the effects of a multimodal mind-body program, the SMART Program, on AF-related quality of life in patients with paroxysmal AF (PAF). METHODS: In this randomized, waitlist-controlled pilot trial, 18 subjects with PAF participated in an 8-week SMART Program delivered online immediately or 3 months later. Validated measures were completed at baseline and at 3 and 6 months (waitlist group only). RESULTS: Comparing pre- vs post-program scores among all 18 participants, subjects reported improvement in AF-related quality of life (Cohen’s d = 0.75, P = .005) and depression (d = 0.50, P = .05) but not anxiety (d = 0.35, P = .16). Subjects also reported improvements in AF symptom severity (P = .026), distress (P = .014), positive affect (P = .003), and ability to cope with stress (P = .001). Compared to waitlist control subjects, those in the immediate group reported improvement in positive affect (d = 1.20, P = .021) and coping with stress (d = 1.36, P = .011) after participating in the program. CONCLUSION: The SMART Program, delivered virtually, may enhance positive emotions and coping with stress as well as decrease negative emotions and AF symptoms. These results warrant a larger trial to better understand the potential benefits of such programs for patients with PAF. Elsevier 2021-06-22 /pmc/articles/PMC8369288/ /pubmed/34430937 http://dx.doi.org/10.1016/j.hroo.2021.06.003 Text en © 2021 Heart Rhythm Society. Published by Elsevier Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Clinical
Dossett, Michelle L.
Needles, Emma W.
Donahue, Zachary
Gadenne, Gillian
Macklin, Eric A.
Ruskin, Jeremy N.
Denninger, John W.
A SMART approach to reducing paroxysmal atrial fibrillation symptoms: Results from a pilot randomized controlled trial
title A SMART approach to reducing paroxysmal atrial fibrillation symptoms: Results from a pilot randomized controlled trial
title_full A SMART approach to reducing paroxysmal atrial fibrillation symptoms: Results from a pilot randomized controlled trial
title_fullStr A SMART approach to reducing paroxysmal atrial fibrillation symptoms: Results from a pilot randomized controlled trial
title_full_unstemmed A SMART approach to reducing paroxysmal atrial fibrillation symptoms: Results from a pilot randomized controlled trial
title_short A SMART approach to reducing paroxysmal atrial fibrillation symptoms: Results from a pilot randomized controlled trial
title_sort smart approach to reducing paroxysmal atrial fibrillation symptoms: results from a pilot randomized controlled trial
topic Clinical
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369288/
https://www.ncbi.nlm.nih.gov/pubmed/34430937
http://dx.doi.org/10.1016/j.hroo.2021.06.003
work_keys_str_mv AT dossettmichellel asmartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial
AT needlesemmaw asmartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial
AT donahuezachary asmartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial
AT gadennegillian asmartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial
AT macklinerica asmartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial
AT ruskinjeremyn asmartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial
AT denningerjohnw asmartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial
AT dossettmichellel smartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial
AT needlesemmaw smartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial
AT donahuezachary smartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial
AT gadennegillian smartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial
AT macklinerica smartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial
AT ruskinjeremyn smartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial
AT denningerjohnw smartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial